To investigate chronic lymphocytic leukemia (CLL)-initiating cells, we assessed NOTCH1 mutation/expression in hematopoietic stem cells (HSCs). In NOTCH1-mutated CLL, we detected subclonal mutations in 57% CD34+/CD38-HSCs. NOTCH1 mutation was present in 66% CD34+/CD38+ progenitor cells displaying an increased mutational burden compared to HSCs. Flow cytometric analysis revealed significantly higher NOTCH1 activation in CD34+/CD38-and CD34+/CD38+ cells from CLL patients, regardless NOTCH1 mutation compared to healthy donors. Activated NOTCH1 resulted in overexpression of the NOTCH1 target c-MYC. We conclude that activated NOTCH1 is an early event in CLL that may contribute to aberrant HSCs in this disease.

NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells / Di Ianni, M., Baldoni, S., Del Papa, B., Aureli, P., Dorillo, E., De Falco, F., Albi, E., Varasano, E., Di Tommaso, A., Giancola, R., Accorsi, P., Rotta, G., Rompietti, C., Barcelos, E.C.S., Campese, A.F., Di Bartolomeo, P., Screpanti, I., Rosati, E., Falzetti, F., Sportoletti, P.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - ELETTRONICO. - 8:APR(2018), pp. 1-7. [10.3389/fonc.2018.00105]

NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells

Campese, Antonio Francesco;Screpanti, Isabella;
2018

Abstract

To investigate chronic lymphocytic leukemia (CLL)-initiating cells, we assessed NOTCH1 mutation/expression in hematopoietic stem cells (HSCs). In NOTCH1-mutated CLL, we detected subclonal mutations in 57% CD34+/CD38-HSCs. NOTCH1 mutation was present in 66% CD34+/CD38+ progenitor cells displaying an increased mutational burden compared to HSCs. Flow cytometric analysis revealed significantly higher NOTCH1 activation in CD34+/CD38-and CD34+/CD38+ cells from CLL patients, regardless NOTCH1 mutation compared to healthy donors. Activated NOTCH1 resulted in overexpression of the NOTCH1 target c-MYC. We conclude that activated NOTCH1 is an early event in CLL that may contribute to aberrant HSCs in this disease.
2018
CD34+ cells; Chronic lymphocytic leukemia; Hematopoietic stem cells; Notch signaling; NOTCH1 mutation; Oncology; Cancer Research
01 Pubblicazione su rivista::01a Articolo in rivista
NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells / Di Ianni, M., Baldoni, S., Del Papa, B., Aureli, P., Dorillo, E., De Falco, F., Albi, E., Varasano, E., Di Tommaso, A., Giancola, R., Accorsi, P., Rotta, G., Rompietti, C., Barcelos, E.C.S., Campese, A.F., Di Bartolomeo, P., Screpanti, I., Rosati, E., Falzetti, F., Sportoletti, P.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - ELETTRONICO. - 8:APR(2018), pp. 1-7. [10.3389/fonc.2018.00105]
File allegati a questo prodotto
File Dimensione Formato  
Di Ianni_notch1_2018.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.57 MB
Formato Adobe PDF
1.57 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1117302
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact